Significance of Measurable Residual Disease in Adult Philadelphia Chromosome–Positive ALL: A GRAAPH-2014 StudyRathana Kim, Emmanuelle Clappier, Emmanuel Raffoux et al.|Journal of Clinical Oncology|2024Cited by 39
Adult T-cell acute lymphoblastic leukemias with IL7R pathway mutations are slow-responders who do not benefit from allogeneic stem-cell transplantationLudovic Lhermitte, Rathana Kim, Nicolas Boissel et al.|Leukemia|2020Cited by 27
Frontline Consolidation with Blinatumomab for High-Risk Philadelphia-Negative Acute Lymphoblastic Adult Patients. Early Results from the Graall-2014-QUEST Phase 2Nicolas Boissel, Hervé Dombret, Françoise Huguet et al.|Blood|2021Cited by 23
Blinatumomab during Consolidation in High-Risk Philadelphia Chromosome (Ph)-Negative B-Cell Precursor (BCP) Acute Lymphoblastic Leukemia (ALL) Adult Patients: A Two-Cohort Comparison within the Graall-2014/B StudyNicolas Boissel, Hervé Dombret, Françoise Huguet et al.|Blood|2022Cited by 23
Frequency and Outcome of Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia with BCR-ABL1 Clonal Hematopoiesis after Blast Clearance: Results from the Graaph-2014 TrialRathana Kim, Emmanuelle Clappier, Philippe Rousselot et al.|Blood|2021Cited by 9